[BUSINESS]■ STORY TIMELINE
PANDE EXITS A16Z BIOTECH FOR SMALLER AI-FOCUSED FUND
Vijay Pande has left Andreessen Horowitz's $4 billion biotech practice to launch VZVC, a smaller AI-native venture fund focused on transforming drug discovery through engineering principles rather than traditional discovery methods.
TechCrunch+0m
Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC —…